SCHEMBL4588778

SCHEMBL4588778

O=C1N=C2CC=C(Br)C=C2C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10602658 0.45
SCHEMBL16618178 0.45
SCHEMBL3754347 0.43
SCHEMBL17717531 0.41
SCHEMBL1825061 0.41 IDH1 (0.30)
SCHEMBL1199564 0.40
SCHEMBL247869 0.39
SCHEMBL1392535 0.37 P2RX7 (0.33)
SCHEMBL11572133 0.37 IDH1 (0.32)
SCHEMBL1599923 0.35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912648-A2 QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-04-23 EP disclosed
WO-2007014941-A2 QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2007-02-08 WO disclosed
EP-1713776-A1 QUINOLINE DERIVATIVES FOR USE AS MYCOBACTERIAL INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-25 EP disclosed
WO-2005075428-A1 QUINOLINE DERIVATIVES FOR USE AS MYCOBACTERIAL INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-08-18 WO disclosed